FcRn Protein (Transcript Variant 2)

N° du produit ABIN2720991

Cette protéine Recombinant FcRn est produite dans HEK-293 Cells.

Aperçu rapide pour FcRn Protein (Transcript Variant 2) (ABIN2720991)

Antigène: FcRn (neonatal Fc Receptor (FcRn))

Type de proteíne: Recombinant

Origine: Humain

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Pureté: > 95 % as determined by SDS-PAGE and Coomassie blue staining

Détail du produit

Attributs du protein: Transcript Variant 2

Attributs du produit:

• Recombinant human FCGRT / FCRN (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

niveau d'endotoxine: Endotoxin level is <0.1 ng/μg of protein (<1EU/μg).

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Restrictions: For Research Use only

Stockage

Buffer: Lyophilized from a 0.2 μM filtered solution of PBS, pH 7.4

Conseil sur la manipulation: Always centrifuge tubes before opening. Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100 μg/mL. Dissolve the lyophilized protein in 1X PBS. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: FcRn (neonatal Fc Receptor (FcRn))

Autre désignation: Fcgrt,fcrn

Sujet: This gene encodes a receptor that binds the Fc region of monomeric immunoglobulin G. The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta. This protein also binds immunoglobulin G to protect the antibody from degradation. Alternative splicing results in multiple transcript variants.

Poids moléculaire: 41.4kD

NCBI Accession: NP_004098

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process